(Q37858927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

review article

1 reference

title

Allogeneic mesenchymal stem cells: agents of immune modulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

mesenchymal stem cell

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Bernard P. Mahon

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Bernard P Mahon

series ordinal

2

1 reference

24 August 2017

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Biochemistry

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1963-1968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21445861%20AND%20SRC:MED&resulttype=core&format=json

Mesenchymal stem cells suppress B-cell terminal differentiation.

26 January 2020

cites work

1 reference

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

"Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease

21 January 2018

1 reference

21 January 2018

Mesenchymal stem cells

1 reference

Why are MSCs therapeutic? New data: new insight.

21 January 2018

1 reference

Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells

21 January 2018

1 reference

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.

21 January 2018

1 reference

Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance.

21 January 2018

1 reference

Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.

21 January 2018

1 reference

Immunological aspects of allogeneic mesenchymal stem cell therapies

21 January 2018

1 reference

Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium

21 January 2018

1 reference

Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair

21 January 2018

1 reference

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

21 January 2018

1 reference

Immunogenicity of Human Mesenchymal Stem Cells in HLA-Class I-Restricted T-Cell Responses Against Viral or Tumor-Associated Antigens

21 January 2018

1 reference

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells

21 January 2018

1 reference

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses

21 January 2018

1 reference

Toll-like receptors and their ligands control mesenchymal stem cell functions

21 January 2018

1 reference

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease

21 January 2018

1 reference

Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction

21 January 2018

1 reference

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner

21 January 2018

1 reference

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche

21 January 2018

1 reference

The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function

21 January 2018

1 reference

Mesenchymal stem cells stimulate antibody secretion in human B cells.

21 January 2018

1 reference

Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.

21 January 2018

1 reference

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation

21 January 2018

1 reference

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

21 January 2018

1 reference

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses

21 January 2018

1 reference

Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.

21 January 2018

1 reference

Mesenchymal stem cells inhibit complement activation by secreting factor H.

21 January 2018

1 reference

Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population

21 January 2018

1 reference